DSM to acquire Aland to strengthen position in vitamin C

The Netherlands based Royal DSM, a global science-based company active in health, nutrition and materials, has reached agreement to acquire Aland Holding, a Hong Kong-based company producing vitamin C in mainland China on July 11. Financial details were not disclosed at that time. Subject to customary conditions, the transaction is expected to close in the next six to nine months. DSM previously announced on April 9 that it was in exclusive discussions to acquire Aland.

Acquiring Aland, one of the leading vitamin C manufacturers in China, allows DSM to further strengthen its position in vitamin C. Aland increases DSM’s global footprint in vitamins for Human Nutrition and Health, Animal Nutrition and Health and Personal Care. DSM remains fully committed to its current vitamin C manufacturing facility in Dalry (Scotland, United Kingdom). The acquisition fully meets DSM’s financial and strategic requirements.

Vitamin C, the world’s largest vitamin measured by volume, is an essential health ingredient that the body cannot produce itself and that needs to be absorbed through diet or supplementation. Vitamin C is widely found in fruit and vegetables. The recommended dietary allowances for vitamin C in the United States were recently revised upwards to 90 mg/day for men and 75 mg/day for women.